The industry is moving away from a traditional, complex pricing model and toward the “cost-plus” approach introduced by billionaire Mark Cuban at his pharmacy company.
PBM law in Oklahoma is unconstitutional, federal court rules modernhealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernhealthcare.com Daily Mail and Mail on Sunday newspapers.
Teva Pharmaceutical
Industries will still pursue launching a biosimilar of
AbbVie s blockbuster arthritis drug Humira next year
despite a crowded marketplace, Chief Executive Richard Francis
said on.
By Steven Scheer JERUSALEM (Reuters) -Teva Pharmaceutical Industries will still pursue launching a biosimilar of AbbVie s blockbuster arthritis drug Humira .